CNV in AMD Analyzed by OCT Angiography Under IntravitreaL Eylea (COCTAEyl)

NCT03803631 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 49

Last updated 2025-09-02

No results posted yet for this study

Summary

The main objective of this study is to analyze a new noninvasive imaging examination, OCT angiography, in the evaluation of neovascular remodeling and early signs of recurrence of wet AMD undergoing treatment on OCTA and to correlate OCTA findings with SD-OCT findings.

Conditions

  • AMD
  • Exudative Macular Degeneration

Sponsors & Collaborators

  • Bayer

    collaborator INDUSTRY
  • Centre Hospitalier Intercommunal Creteil

    lead OTHER

Eligibility

Min Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-04
Primary Completion
2021-11-15
Completion
2021-11-15

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03803631 on ClinicalTrials.gov